APLS - Financial Reports List - Apellis Pharmaceuticals, Inc. - IntrinsicAlpha

Apellis Pharmaceuticals, Inc. APLS

Healthcare - Biotechnology - NASDAQ - US

$ 19.8

-0.851 %

$ 2.49 B

Market Cap

-12.37

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	45.19%	58.96%	69.04%
Annual Report	FY	10-K	2024-12-31	79.01%	62.57%	54.29%
Quarterly Report	Q3	8-K	2024-09-30	98.45%	59.04%	68.12%
Quarterly Report	Q2	8-K	2024-06-30	110.26%	69.14%	75.55%
Quarterly Report	Q1	8-K	2024-03-31	284.26%	62.64%	64.54%
Quarterly Report	Q4	8-K	2023-12-31	545.89%	46.64%	48.48%
Annual Report	FY	10-K	2023-12-31	425.83%	18.94%	13.03%
Quarterly Report	Q3	8-K	2023-09-30	349.68%	26.68%	3.03%
Quarterly Report	Q2	8-K	2023-06-30	481.85%	21.76%	18.96%
Quarterly Report	Q1	8-K	2023-03-31	211.84%	-27.96%	-35.73%

1